2021-11-16-世界卫生组织-Cervical_cancer_Canada_2021_country_profile_1页_63kb

Canada Cervical Cancer Profile

Morbidity and Mortality

• Incidence: Age-standardized rate 5.5 per 100,000 women (2020), crude rate per 100,000 not specified.
• Mortality: 580 deaths (2019) for female cervical cancer.
• Mortality-to-incidence ratio: 0.45 (2020).
• Cumulative risk: Data not available.
• Risk factors: Tobacco use prevalence 0.5% among women aged 15+ (2020), condom use and HIV incidence data not fully specified (HIV incidence per 1,000: 10%; report incomplete).

Primary Prevention

• HPV Vaccination Program: National coverage 87% among girls, introduced in 2009 by age 15, scale high, primary target 9-14-year-old girls, 87% vaccinated by age 15.
• Program details: Final dose coverage 87%, 100% of target population vaccinated, development of guidelines no year specified.

Secondary Prevention

• Screening Program: National program exists (2021), primary screen test cytology, target age range 25-69 years.
• Awareness: 80% of women screened within last 5 years, 91% have been screened ever.
• Early detection: Guidelines exist for strengthening detection at primary health care level, referral system defined.

Treatment and Supportive Care

• Guidelines: National cervical cancer management guidelines available (2021).
• Resources: Limited data updates, but indicate availability of cancer centers, pathology services, and specific personnel (e.g., radiation oncologists, surgeons) reported from 2013 or later.

Data Overview

• Total female population: 18,850,000 (2019).
• Female deaths: 136,000 (2019).
• Elimination targets under WHO strategy: Key metrics for reduction by 2030 are referenced but without full metrics provided.